The global Gynecological Devices market was valued at $9.4 billion in 2018 and is anticipated to grow at a CAGR of 7.9% during the forecast period. Gynecological devices include instruments and devices used for the treatment of diseases related to the female reproductive system. These devices include surgical devices, handheld instruments, diagnostic imaging systems, and software associated with the devices. Surgical gynecological devices include endoscopy devices, laparoscope, Colposcope, Hysteroscopes, Hysteroscopic insufflator, and laparoscopic insufflator among others.These devices are usually manufactured using stainless steel for improved efficiency and reduced chances of infection. Gynaecological devices are used in hospitals, clinics,diagnostic centres, and research institutes for surgical and examination applications.
The global gynecological devices market is influenced by factors such as increasing female population, and rising awareness regarding reproductive health. The growing awareness regarding sexually transmitted diseases in women,coupled with preventive healthcare measures supports the gynecological devices market growth. Improving lifestyles, and increasing disposable income, especially in the emerging economies of Asia-Pacific has increased the demand for gynecological devices. The growing geriatric population, and rising adoption of minimal invasive procedures further accelerate the adoption of gynecological devices.Significant growth in healthcare expenditure, increasing demand for disposable equipment, and rising gynecological disorders, such as polycystic ovarian syndrome (PCOS), ovarian cancer, cervical cancer, and uterine cancer are factors expected to drive the market growth during the forecast period. The growing demand from the emerging economies, technological advancements, and increasing consumer awareness are factors expected to provide numerous growth opportunities in the coming years.
Global Gynecological Devices Market, By Device
Global Gynecological Devices Market, By End-Users
Global Gynecological Devices Market, by Geography
The market research study on “Gynecological Devices Market (By Device: Surgical Devices [Endoscopy Devices, Fluid Management Systems, Endometrial Ablation Devices, Contraceptive Devices, Others], Diagnostic Imaging Systems [Ultrasound, Mammography, MRI, Others], Hand Held Instruments [Biopsy Forceps, Tenaculum, Curettes, Others], Software, Others; By End-Users: Hospitals, Clinics, Diagnostic Centres, Research Institutes, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2026” offers a detailed insight of the global Gynecological Devices market with analysis of its market segments. Market dynamics with drivers, restraints and opportunities along with their impact on the global market are provided in the report.
This market report comprises a detailed geographic analysis of the Gynecological Devices market across North America, Europe, Asia-Pacific, Latin America, and MEA. North America is further segmented into U.S., Canada, and Mexico. Europe is divided into Germany, UK, Italy, France, Spain, and Rest of Europe. Asia-Pacific is bifurcated into China, India, Japan, Australia, and Rest of Asia-Pacific. The analysis of Latin America includes Brazil, Chile, and rest of Latin America, whereas MEA includes South Africa, Saudi Arabia, and rest of MEA.Asia-Pacific is expected to grow at a significant rate during the forecast period owing to growing population, rising disposable incomes in developing countries of this region, and rising awareness regarding contraceptive procedures to control population.
Some major players operating in the global Gynecological Devices market include Ethicon, Inc., Richard Wolf GmbH, Olympus Corporation, Cooper Surgical Inc., Hologic Inc., Medtronic plc, Boston Scientific Corporation, Koninklijke Philips Electronics NV, Johnson & Johnson, Siemens AG, and Fresenius Medical Care AG & Co. KGAAamong others. These players are investing in technological development, and are launching new products to cater to the growing demand for consumers. Global players are entering new developing economies for expansion of customer base, and strengthening market presence.
Introduction: Meningococcal vaccines are utilized to treat meningitis brought about by bacterium N. meningitidis. Beforehand there were no careful steps accessible to maintain a strategic distance from meningitis. Anti-infection agents alongside supplement supplements were utilized to treat this ailment after the disease was affirmed. In any case, with the approach of the meningoco
Introduction According to Acumen Research and Consulting, the global Sports Medicine market is expected to grow at noteworthy CAGR around 7% throughout the forecast period and reach around US$ 13 billion by 2026. Sports Medicine is a genetic disorder that causes structural abnormalities in hemoglobin molecules. Hemoglobinopathie
Introduction According to Acumen Research and Consulting, the global Real-time PCR (qPCR) & Digital PCR (dPCR) market is expected to grow at noteworthy CAGR around 8.1 % throughout the forecast period and reach around US$ 4.2 billion by 2026. In order to amplify or make more copies of the deoxyribonucleic acid (DNA) sequence
Introduction According to Acumen Research and Consulting, the global Nebulizer market is expected to grow at noteworthy CAGR around 6.2 % throughout the forecast period and reach around US$ 1.4 billion by 2026. Nebulizer is a medical device that converts the medicine into a nebula and directly into the pulmonary system. Nebuliza
Introduction According to Acumen Research and Consulting, the global Motion Preservation Devices market is expected to grow at noteworthy CAGR around 10.5 % throughout the forecast period and reach around US$ 1.5 billion by 2026. In spinal disorders, movement preservation devices are used. Motion conservation devices are used to
Introduction According to Acumen Research and Consulting, the global Hemoglobinopathy market is expected to grow at noteworthy CAGR around 10 % throughout the forecast period and reach around US$ 12 billion by 2026. Hemoglobinopathy is a genetic disorder that causes structural abnormalities in hemoglobin molecules. Hemoglobinopa